Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Supplement Upper Level EU/U.S. Harmonization Is TABD Priority

This article was originally published in The Tan Sheet

Executive Summary

The dietary supplements working group of the TransAtlantic Business Dialogue has agreed to focus on urging the EU Scientific Committee on Food and the U.S. Food & Nutrition Board to harmonize their efforts at setting safe upper levels for vitamins and minerals.

You may also be interested in...



Vitamin/Mineral Raw Material Suppliers EC Dossier Submissions Urged

Raw material suppliers of vitamins or minerals not included on the European Commission's positive list of food supplements should submit dossiers for the ingredients' addition to the list as soon as possible, supplement industry reps advise

Vitamin/Mineral Raw Material Suppliers EC Dossier Submissions Urged

Raw material suppliers of vitamins or minerals not included on the European Commission's positive list of food supplements should submit dossiers for the ingredients' addition to the list as soon as possible, supplement industry reps advise

Vitamin/Mineral Raw Material Suppliers EC Dossier Submissions Urged

Raw material suppliers of vitamins or minerals not included on the European Commission's positive list of food supplements should submit dossiers for the ingredients' addition to the list as soon as possible, supplement industry reps advise

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS091944

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel